IP Library Granted Patent US 10,123,960
Granted Patent B2
US 10,123,960 · App. 15/036,467 · Granted Nov 13, 2018

Methods for treating of skin conditions with retinoid double conjugate compounds

Inventor: Joseph A. Lewis, II (Chesterfield, VA)
Assignee: PCR TECHNOLOGY HOLDINGS, LC
A61K8/671A61Q19/00A61Q19/08C07C403/20C07C2601/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,123,960
App. No.
15/036,467
Granted
Nov 13, 2018
Kind
B2
Abstract

A double conjugate molecule made of a retinoid, an organic acid, particularly an a-hydroxy acid, and an alcohol or acyl group, is provided which is useful in treating skin conditions, particularly aging. The retinoid, organic acid, and alcohol/acyl group are preferably linked via ester bonds.

Claims (16)

1. A method of treating a skin condition in a human, comprising:

contacting the skin of the human in need of such treatment with an effective amount of a composition comprising the molecule of formula (Id),

wherein

R 3 is H or alkyl consisting of 1 carbon atom, and

R 6 is alkyl consisting of 1, 2, 3, or 4 carbon atoms; and

wherein the skin condition is acne, photodamage, fine lines and wrinkles, or a combination thereof.

2. The method of claim 1 , wherein the composition further comprises:

a carrier; and

0.01 to 0.5 wt %, relative to the total weight of the composition, of the molecule of formula Id.

3. The method of claim 1 , wherein the composition further comprises:

an α-hydroxy acid.

4. The method of claim 1 , wherein the molecule has the formula (If)

5. The method of claim 1 , wherein the molecule has the formula (Ig)

6. The method of claim 1 , wherein the molecule of formula (Id) is present in an amount of 0.01 to 0.25 wt %.

7. The method of claim 1 , wherein the molecule of formula (Id) is present in an amount of 0.01 to less than 0.2 wt %.

8. The method of claim 1 , wherein the molecule of formula (Id) is present in the amount of 0.02 to 0.175 wt %.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2022
From: PCR TECHNOLOGY HOLDINGS, LC
To: DERMAFORCE HOLDINGS, LLC
Reel/Frame 061031/0852 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2017
From: US COSMECEUTECHS, LLC
To: PCR TECHNOLOGY HOLDINGS, LC
Reel/Frame 040854/0052 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2016
From: LEWIS, JOSEPH A., II
To: US COSMECEUTECHS LLC
Reel/Frame 038640/0169 →
Continuity (2)
Provisional Application 61904532 · Nov 15, 2013
Related Publication 20160287507A1 · Oct 6, 2016